Nonsteroidal Mineralocorticoid Receptor Antagonists in Heart Failure: Mechanistic Basis, Clinical Evidence, and Therapeutic Integration
The therapeutic landscape for heart failure (HF), particularly in patients with mildly reduced (HFmrEF) and preserved ejection fraction (HFpEF), has historically been characterized by limited effective disease-modifying options. The recent approval of nonsteroidal mineralocorticoid receptor antagoni...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI AG
2026-05-01
|
| Serie: | Drugs and Drug Candidates |
| Soggetti: | |
| Accesso online: | https://www.mdpi.com/2813-2998/5/2/33 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|